AZTA Azenta, Inc.
Q4 2025 10-Q
Azenta, Inc. (AZTA) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 5, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ4 2025 10-Q
Management Discussion & Analysis
- • Revenue $148.6M, up 0.8% YoY; Sample Management Solutions $81.4M up 0.4%, Multiomics $67.2M up 1.4%
- • Operating margin Sample Management 4.6% vs 5.0% YoY, Multiomics -7.5% vs -4.8%, total company -0.9% vs 0.6%
Risk Factors
- • No new or materially updated risk factors disclosed this quarter compared to 2025 10-K
- • Continued risk of intellectual property disputes impacting proprietary technology and trademarks
Get deeper insights on Azenta, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.